1 not yet recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Not yet recruiting 1 |
Follow DWP14012 40mg (Fexuprazan): new trials by email Literature Review of DWP14012 40mg (Fexuprazan) trials Research Report on DWP14012 40mg (Fexuprazan)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 3 to Evaluate the Efficacy and Safety of DWP14012 in Patients With Gastric Ulcer DWP14012 40mg (Fexuprazan), Lansoprazole 30mg - Gastric Ulcer | Phase 3 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 384 | 2026-10-15 | 2026-07-28 |
Duodenal Ulcer (1) · Peptic Ulcer (1) · Stomach Ulcer (1)
Daewoong Pharmaceutical Co. LTD. (1)
Indonesia (1) · South Korea (1)